The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 12 September 2018 the Company bought 5 434 own shares representing 0.004% of the share capital of the Company, at a total value of 22 528.43 BGN on the Bulgarian Stock Exchange, the average price per share was 4.146 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 154 310, representing 6.79% of the share capital of the Company.
Sopharma AD notifies that on 11 September 2018 the Company bought 28 own shares representing 0.00002% of the share capital of the Company, at a total value of 115.64 BGN on the Bulgarian Stock Exchange, the average price per share was 4.13 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 148 876, representing 6.79% of the share capital of the Company.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) draws attention to the fact that the registration for participation in the Extraordinary General meeting convened on 14 September 2018 will end at 10:45 am to comply with the opening hours announced for the start of the general meeting for the convenience of all shareholders.